Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(21)
DRUG(5)
BIOLOGICAL(2)
Cyclophosphamide
2 trials
phase_1phase_1_2
md-anderson-cancer-center
Fludarabine Phosphate
2 trials
phase_1phase_1_2
md-anderson-cancer-center
Tacrolimus
2 trials
phase_1phase_1_2
md-anderson-cancer-center
Laboratory Biomarker Analysis
2 trials
phase_1phase_2
md-anderson-cancer-center
Allogeneic Hematopoietic Stem Cell Transplantation
2 trials
phase_1phase_1_2
md-anderson-cancer-center
Umbilical Cord Blood Transplantation
1 trial
phase_1
md-anderson-cancer-center
Melphalan
1 trial
phase_1
md-anderson-cancer-center
Mycophenolate Mofetil
1 trial
phase_1
md-anderson-cancer-center

+15 more interventions

23 unique interventions3 categories

Analytics

Trial Phases

Phase 14
Phase 23

Trial Status

Completed1
Recruiting2
Terminated1
Other1

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT06414889Phase 1Recruiting
Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder
RUNX1 Familial Platelet Disorder
PrincipalinvestigatorStart date: 2024-05-20
NCT05110742Phase 1/2Recruiting
Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances
Hematological Malignancy
PrincipalinvestigatorStart date: 2024-04-22
NCT02530515Phase 2Completed
Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia
AnemiaCancer FatigueChronic Lymphocytic Leukemia+11 more
PrincipalinvestigatorStart date: 2015-12-18
NCT01619761Phase 1Unknown
NK Cells in Cord Blood Transplantation
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in Remission+22 more
PrincipalinvestigatorStart date: 2013-05-03
NCT01629511Phase 1/2Terminated
Allogeneic Stem Cell Transplant for CLL
Allogeneic Hematopoietic Stem Cell Transplantation RecipientChronic Lymphocytic LeukemiaProlymphocytic Leukemia+1 more
PrincipalinvestigatorStart date: 2012-11-21

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellHematologic Neoplasms
Similarity Score1%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Hematologic NeoplasmsMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Myelodysplastic SyndromesAnemia

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score1%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Myelodysplastic SyndromesHematologic Neoplasms
Similarity Score1%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellWeight Loss
Similarity Score1%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

Myelodysplastic SyndromesHematologic Neoplasms

Worked with same sponsors:

M.D. Anderson Cancer Center
Similarity Score1%

Abhik Das, PhD

RTI International

Related
31 trials

Shared therapeutic areas:

Anemia
Similarity Score1%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Fever
Similarity Score1%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Weight Loss
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT06414889Phase 1PrincipalInvestigator

Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder

RUNX1 Familial Platelet Disorder
Recruiting
NCT05110742Phase 1/2PrincipalInvestigator

Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances

Hematological Malignancy
Recruiting
NCT02530515Phase 2PrincipalInvestigator

Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia

AnemiaCancer FatigueChronic Lymphocytic Leukemia+11 more
Completed
NCT01619761Phase 1PrincipalInvestigator

NK Cells in Cord Blood Transplantation

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in Remission+22 more
Unknown
NCT01629511Phase 1/2PrincipalInvestigator

Allogeneic Stem Cell Transplant for CLL

Allogeneic Hematopoietic Stem Cell Transplantation RecipientChronic Lymphocytic LeukemiaProlymphocytic Leukemia+1 more
Terminated

All 5 trials loaded